Amrutanjan Health Care Limited · NSE:AMRUTANJAN
Amrutanjan Health Care — FY2022 Earnings Presentation
17 slides from Amrutanjan Health Care's earnings presentation, May 25, 2022
Slide 1: Exchange filing cover letter
t ¿ BSE Limited of lndia Limited ffre Uationat Stock Exchange ó.p.t,t.n, of CorPorate Services ii*.f,ung. plaza", C-1, Block,G ,_, 1tt Floor, (E) eTiït. Krtrt comPlex' Bandra P.J. Towers, Dalal Street' Mumbai400 051 Mumbai400 001 lSlN: 1NE098F01031 ScriP Code: 590006 Symbol: AMRUTANJAN Dear Sir / Ma
Slide 2: Amrutanjan Health Care Limited Investor Presentation
Amrutanjan Health Care Limited Investor Presentation - Quarter & Year Ended 31st March 2022 Date: 24th May 2022
Slide 3: Contents
Contents a. Business Update b. FY22 Performance c. Q4 FY22 Performance d. Way Forward Investor Presentation | Quarter and Year Ended 31st March 2022 2
Slide 4: Business Update
Business Update Investor Presentation | Quarter and Year Ended 31st March 2022 3
Slide 5: Business Update
Business Update • Comfy, Roll-On for Head, Body and Electro Plus continue to be growth drivers. • Covid related growth is not seen anymore. • Super Stockist net work continues to be built to drive rural penetration. • Comfy is the 4th largest Sanitary Napkin brand in India by volume market share (So
Slide 6: FY22 Performance
FY22 Performance Investor Presentation | Quarter and Year Ended 31st March 2022 5
Slide 7: Financials – FY22
Financials – FY22 (Rs. in Crores) Gross Sales Profit Before Tax 455.85 367.78 90.58 81.90 FY22 FY21 FY22 FY21 Growth: 23.95% Growth: 10.60% Gross Sales - E Comm. Profit After Tax 67.19 9.55 4.43 61.19 FY22 FY21 FY22 FY21 Growth: 115.58% Growth: 9.81% Investor Presentation | Quarter and Year Ended 31
Slide 8: Financials – FY22
Financials – FY22 (Rs. in Crores) Employee Benefit Expenses 48.23 41.70 FY22 FY21 Increase: 15.66% Advertisement & Selling Expenses Other Expenses 55.03 42.64 30.21 45.99 FY22 FY21 FY22 FY21 Increase: 19.66% Increase: 41.15% Investor Presentation | Quarter and Year Ended 31st March 2022 7
Slide 9: Financials – FY22 – OTC Division
Financials – FY22 – OTC Division (Rs. in Crores) Gross Sales - OTC 416.73 346.75 Notes: • Key raw material - Menthol Crystal price is lower when compared to FY21. FY22 FY21 • The prices of packing materials are Growth: 20.18% higher when compared to FY21. Gross Sales - Comfy 69.50 • Advertisement sp
Slide 10: Financials – FY22 – Beverage Division
Financials – FY22 – Beverage Division (Rs. in Crores) Gross Sales - Beverages 37.34 Notes: 19.51 • Gross Margin has improved by 1,131 basis points when compared to FY22 FY21 FY21 mainly due to product mix. Growth: 91.39% • Advertisement spend is at 5.57 cr Gross Sales - Electro Plus for FY22 against
Slide 11: Key Financial Ratios
Key Financial Ratios Return on Capital Employed % Operating Profit Margin (%) 38.00% 25.00% 24.76% 37.09% 37.00% 24.50% 36.00% 24.00% 35.00% 23.50% 23.00% 22.44% 34.00% 33.43% 22.50% 33.00% 22.00% 32.00% 21.50% 31.00% 21.00% FY22 FY21 FY22 FY21 Debtors Turnover Ratio Inventory Turnover Ratio 16.00 1
Slide 12: Q4 FY22 Performance
Q4 FY22 Performance Investor Presentation | Quarter and Year Ended 31st March 2022 11
Slide 13: Financials – Q4 FY22
Financials – Q4 FY22 (Rs. in Crores) Gross Sales Profit Before Tax Profit After Tax 124.37 20.02 14.71 13.71 10.23 104.74 Q4 FY22 Q4 FY21 Q4 FY22 Q4 FY21 Q4 FY22 Q4 FY21 Growth: 18.74% Growth: 46.02% Growth: 43.79% Investor Presentation | Quarter and Year Ended 31st March 2022 12
Slide 14: Financials – Q4 FY22
Financials – Q4 FY22 (Rs. in Crores) Gross Sales - OTC Gross Sales - Beverages 108.94 14.83 9.88 94.31 Q4 FY22 Q4 FY21 Q4 FY22 Q4 FY21 Growth: 15.51% Growth: 50.10% Gross Sales - Comfy Gross Sales - Electro Plus 18.66 12.93 14.74 6.78 Q4 FY22 Q4 FY21 Q4 FY22 Q4 FY21 Growth: 26.59% Growth: 90.71% Inv
Slide 15: Way Forward
Way Forward Investor Presentation | Quarter and Year Ended 31st March 2022 14
Slide 16: Way Forward
Way Forward We remain focused on executing our key priorities: • Expand distribution • Go global • Go digital • Grow E-Commerce vertical • Costs control Investor Presentation | Quarter and Year Ended 31st March 2022 15
Slide 17: Investor Presentation | Quarter and Year Ended 31st March 2022
Investor Presentation | Quarter and Year Ended 31st March 2022 16
Amrutanjan Health Care — FY2022 Earnings Presentation on 6ix